Skip to main content
Premium Trial:

Request an Annual Quote

NeoGenomics to Offer Response Genetics' Colorectal, Lung Cancer Tests

NEW YORK (GenomeWeb News) – Clinical lab services company NeoGenomics will offer two of Response Genetics’ tests, one for colon cancer and another for lung cancer, the companies said today.
NeoGenomics will exclusively offer the ResponseDX: Colon test for colorectal cancer and the ResponseDX: Lung test for non-small-cell lung cancer through its US sales force, the companies said.
All of the tests contracted under the agreement will be performed through Response Genetics’ CLIA-certified lab. These PCR-based tests are aimed at helping doctors make treatment decisions for patients with colorectal and lung cancer.
The ResponseDX panels include analysis of the KRAS mutation, gene expression profiling of RRM1, and up to three other patent-protected genes, including ERCC1, TS, and EGFR.
The KRAS mutation is used as a predictor of whether patients will respond to the common treatment regimens for these types of cancers. Gene expression results from the panels are used to help oncologists choose between several standard chemotherapy regimens.
Response Genetics also noted that it has formed a specialized sales team to market the ResponseDX tests.
NeoGenomics Chief Scientific Officer Robert Gasparini said the joint sales strategy “will allow us to establish new accounts, differentiate our services, and increase our footprint in the expanding field of molecular cancer genetics.”
Ft. Myers, Fla.-based NeoGenomics’ testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, morphology studies, anatomic pathology, and molecular genetic testing.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.